FDA finds small amounts of probable carcinogen in Zantac and other heartburn drugs
9:17am PDT - September 13th, 2019 zantac - USA TodayThe FDA tested ranitidine heartburn medications and found small amounts of a probable carcinogen. The agency has not recommended the drugs be recalled